Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is a phase 1 (first in man) study testing the safety of adding high dose ascorbate
(vitamin C) to standard radiation and chemotherapy for treatment of pancreatic cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Joseph J. Cullen
Collaborators:
Gateway for Cancer Research Holden Comprehensive Cancer Center